Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges — Daisong Wang (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
Shared by
Hans Clevers
Utrecht University
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
Article
2025
en
Authors
+1 more
DW
Daisong Wang
RV
Remi Villenave
NS
Nadine Stokar‐Regenscheit
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2012
Challenges for Academic Drug Discovery
William L. Jorgensen
Angewandte Chemie International Edition
Article
2021
Canine Pituitary Organoids as 3D <i>In Vitro</i> Model for Cushing Disease
Karin Sanders
,
Femke Ringnalda
,
Marc L. van de Wetering
,
H.S. Kooistra
,
Björn P. Meij
,
Hans Clevers
,
Sara Galac
Article
2023
Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
Delilah Hendriks
,
Jos F. Brouwers
,
Karien M. Hamer
,
Maarten H. Geurts
,
Léa Luciana
,
Simone Massalini
,
Carmen López‐Iglesias
,
Peter J. Peters
,
Maria J. Rodríguez Colman
,
Susana M. Chuva de Sousa Lopes
,
Benedetta Artegiani
,
Hans Clevers
Article
2013
Silk for Drug Delivery Applications: Opportunities and Challenges
F. Philipp Seib
,
David Kaplan
Article
2018
Drug-Abuse Nanotechnology: Opportunities and Challenges
Morteza Mahmoudi
,
Sepideh Pakpour
,
George Perry
Discussion(0)
No comments yet. Be the first to comment.